15-Year heart study tracks patients after balloon treatment

NCT ID NCT06972225

Recruiting now Knowledge-focused Sponsor: Olivier F. Bertrand Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study reviews the long-term heart health of 1,500 patients who received a drug-eluting balloon to treat coronary artery disease between 2010 and 2025. Researchers will track major heart events like heart attacks, strokes, and repeat procedures. The goal is to better understand the safety and effectiveness of this treatment over many years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: drug-eluting balloon
What this could lead to: If successful, this study could provide valuable long-term safety and effectiveness data for drug-eluting balloons in treating coronary artery disease.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be influenced by other factors and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIFURCATION CORONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder coronary restenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIFURCATION CORONARY DISEASE CORONARY ARTERIAL DISEASE (CAD) RESTENOSIS, CORONARY

15-Year heart study tracks patients after balloon treatment

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions